CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 264 enrolled
Drug / intervention
General SARS-CoV-2 Communication +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06085547
NCT06085547N/ACompleted
CompareCT.gov

Rural Tailored COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake

Michigan State University·interventional·Posted Oct 17, 2023·Updated Jan 17, 2025

In Brief

A clinical study evaluating General SARS-CoV-2 Communication and Rural-Targeted SARS-CoV-2 Communication for SARS-CoV2 Infection. Completed, enrolled 264 participants across 1 site.

Detailed Summary

This study seeks to evaluate communication strategies for better encouraging understanding and uptake of salivary SARS-CoV-2 antibody testing among individuals residing in rural Northern Michigan. This iteration will consider individuals recruited from rural Northern Michigan and assess individuals' willingness to participate in home-based saliva sample collections.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSARS-CoV2 Infection
CountriesUnited States
CollaboratorsJohns Hopkins University, National Cancer Institute (NCI)

Timeline

N/ACompletedFinished
202420252026
First PostedOct 17, 2023
Enrollment StartMay 4, 2023
Primary CompletionNov 14, 2023
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 2.7 years ago

Interventions

General SARS-CoV-2 Communicationbehavioral

SARS-CoV-2 video tutorial is for general consumption and does not include rural-targeted information

Rural-Targeted SARS-CoV-2 Communicationbehavioral

SARS-CoV-2 video tutorial includes a two and a half minute video based messaging adjunct meant to enact a rural-targeted framing of health information presented to White rural individuals.